Guiyan Chu

1.5k citations
56 papers · 1.1k indexed · h-index 20

Guiyan Chu

55 papers receiving 1.1k citations

Peers

Guiyan Chu
Comparison fields: 5 of 95
  • Aging 55
  • Endocrine and Autonomic Systems 183
  • Cancer Research 317
  • Reproductive Medicine 103
  • Physiology 221
Replace Jingli Tao with:
Jingli Tao China
Jianhui Tian China
Yukun Song China
Kyu-Tae Chang South Korea
Lingbin Liu China
Sheng Cui China
Yongju Zhao China
Weihua Du China
Changjiu He China
Guiyan Chu relative to Jingli Tao China Jingli Tao's profile →
Citations per field
00.5×2.6×
Jingli Tao · 1×
Citations per year

Countries citing papers authored by Guiyan Chu

Since Specialization
Citations

This map shows the geographic impact of Guiyan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiyan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiyan Chu more than expected).

Fields of papers citing papers by Guiyan Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiyan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiyan Chu. The network helps show where Guiyan Chu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guiyan Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guiyan Chu Line = papers co-authored together Guiyan Chu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20242
3 20235
4 20233
5 20235
6 20234
7 20226
8 202211
9 201910
10 201847
11 201754
12 201715
13 201713
14 201730
15 201723
16 201647
17 201413
18 201216
19 201228
20 201259

About Guiyan Chu

Guiyan Chu is a scholar working on Aging, Endocrine and Autonomic Systems, Cancer Research, Reproductive Medicine and Physiology, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (13 papers), Reproductive Biology and Fertility (11 papers), MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (7 papers), Adipose Tissue and Metabolism (7 papers), Spaceflight effects on biology (6 papers), Genetics, Aging, and Longevity in Model Organisms (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). The work is most often cited by research in Aging (55 citations), Endocrine and Autonomic Systems (183 citations), Cancer Research (317 citations), Reproductive Medicine (103 citations) and Physiology (221 citations). Guiyan Chu has collaborated with scholars based in China, Japan and Canada. Frequent co-authors include Gongshe Yang, Weijun Pang, Zhihua Liu, Taiyong Yu, Nobuhiko Yamauchi, Seiichi Hashimoto, Masa‐aki Hattori, Zhengrong Yuan, Yasufumi Shigeyoshi and Jing Qin. Their work appears in journals such as Theriogenology, Journal of Animal Science and Biotechnology, International Journal of Molecular Sciences, Molecular Biology Reports and Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026